27 Results

People

  1. Abrey
    Abrey
  2. De Angelis
    De Angelis
  3. Spriggs
    Spriggs
  4. Tew
    Tew
  5. Aghajanian
    Aghajanian
  6. Dupont
    Dupont
  7. Miller
    Miller
  8. Omuro
    Omuro
  9. Abramson
    Abramson
  10. Bach
    Bach

Groups

  1. Department of Medicine (15)
  2. Solid Tumor Oncology Division (14)
  3. GDMT, Medicine (6)
  4. Gynecologic Medicine Service (6)
  5. Gynecology Disease Management Team (6)
  6. Gastrointestinal Oncology Service (4)
  7. Tow Center for Developmental Oncology (TCDO) (4)
  8. Division of Subspecialty Medicine (3)
  9. Epidemiology and Biostatistics (2)
  10. GSK Faculty (2)
  1. "aflibercept"
Formats
  1. Journal Article (26)
  2. Review (1)
Groups
  1. Department of Medicine (15)
  2. Solid Tumor Oncology Division (14)
  3. GDMT, Medicine (6)
  4. Gynecologic Medicine Service (6)
  5. Gynecology Disease Management Team (6)
  6. Gastrointestinal Oncology Service (4)

More Groups

People
  1. David Spriggs (3)
  2. Lauren Abrey (3)
  3. Lisa De Angelis (3)
  4. William Tew (3)
  5. Antonio Omuro (2)
  6. Carol Aghajanian (2)

More People

Years
  1. 2024 (1)
  2. 2020 (2)
  3. 2017 (1)
  4. 2015 (4)
  5. 2014 (2)
  6. 2013 (4)

More Years

Publications
  1. Current Treatment Options in Oncology (2)
  2. Journal of Clinical Oncology (2)
  3. Neuro-Oncology (2)
  4. Targeted Oncology (2)
  5. The Oncologist (2)
  6. BioDrugs (1)

More Publications

Publishers
  1. Springer (6)
  2. Oxford University Press (5)
  3. Elsevier Inc. (3)
  4. American Society of Clinical Oncology (2)
  5. Nature Publishing Group (2)
  6. Adis Data Information Bv (1)

More Publishers

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single-agent and combined modality approaches
    Journal Article

    Beal, K.; Abrey, L. E.; Gutin, P. H.
    Radiation Oncology (2011)

    Fulltext@MSK | Save
  • Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors
    Journal Article

    Tew, W. P.; Gordon, M.; Murren, J.; Dupont, J.; Pezzulli, S.; Aghajanian, C.; Sabbatini, P.; Mendelson, D.; Schwartz, L.; Gettinger, S.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors
    Journal Article

    Maitland, M. L.; Bakris, G. L.; Black, H. R.; Chen, H. X.; Durand, J. B.; Elliott, W. J.; Ivy, S. P.; Leier, C. V.; Lindenfeld, J.; Liu, G.; more...
    JNCI: Journal of the National Cancer Institute (2010)

    Fulltext@MSK | Save
  • A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum-and erlotinib-resistant adenocarcinoma of the lung
    Journal Article

    Leighl, N. B.; Raez, L. E.; Besse, B.; Rosen, P. J.; Barlesi, F.; Massarelli, E.; Gabrail, N.; Hart, L. L.; Albain, K. S.; Berkowitz, L.; more...
    Journal of Thoracic Oncology (2010)

    Fulltext@MSK | Save
  • Therapeutic Advances in Malignant Glioma: Current Status and Future Prospects
    Journal Article

    Robins, H. I.; Lassman, A. B.; Khuntia, D.
    Neuroimaging Clinics of North America (2009)

    Fulltext@MSK | Save
  • Debate: Treatment of patients with recurrent ovarian cancer should be treated with antiangiogenic agents in combination with chemotherapy
    Journal Article

    Boruta, D.; Farley, J.; Birrer, M. J.; Sabbatini, P.
    Clinical Ovarian Cancer (2009)

    Fulltext@MSK | Save
  • Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium
    Journal Article

    Chang, S. M.; Lamborn, K. R.; Kuhn, J. G.; Yung, W. K. A.; Gilbert, M. R.; Wen, P. Y.; Fine, H. A.; Mehta, M. P.; Deangelis, L. M.; Lieberman, F. S.; more...
    Neuro-Oncology (2008)

    Fulltext@MSK | Save